Search by Drug Name or NDC
NDC 00069-0411-02 TicoVac 2.4 ug/.5mL Details
TicoVac 2.4 ug/.5mL
TicoVac is a INTRAMUSCULAR INJECTION in the VACCINE category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED).
Product Information
| NDC | 00069-0411 |
|---|---|
| Product ID | 0069-0411_c646a966-5d4b-4921-8e37-74e6de0b95be |
| Associated GPIs | 1710008610E620 |
| GCN Sequence Number | 044767 |
| GCN Sequence Number Description | tick-borne encephalitis vaccin SYRINGE 2.4MCG/0.5 INTRAMUSC |
| HIC3 | W7J |
| HIC3 Description | NEUROTOXIC VIRUS VACCINES |
| GCN | 42174 |
| HICL Sequence Number | 016557 |
| HICL Sequence Number Description | TICK-BORNE ENCEPHALITIS VACCINE |
| Brand/Generic | Brand |
| Proprietary Name | TicoVac |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Tick-Borne Encephalitis Vaccine |
| Product Type | VACCINE |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 2.4 |
| Active Ingredient Units | ug/.5mL |
| Substance Name | TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED) |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125740 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00069-0411-02 (00069041102)
| NDC Package Code | 0069-0411-02 |
|---|---|
| Billing NDC | 00069041102 |
| Package | 1 SYRINGE in 1 CARTON (0069-0411-02) / .5 mL in 1 SYRINGE (0069-0411-01) |
| Marketing Start Date | 2021-10-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |